BioMark Diagnostics's total assets for Q1 2026 were C$2.66M, a decrease of -15.22% from the previous quarter. TSE:BUX total liabilities were C$1.33M for the fiscal quarter, a -4.82% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.